17959, New Philadelphia, Pennsylvania Prostate Cancer Score Provider Score

The Provider Score for the Prostate Cancer Score in 17959, New Philadelphia, Pennsylvania is 43 when comparing 34,000 ZIP Codes in the United States.

An estimate of 96.27 percent of the residents in 17959 has some form of health insurance. 42.22 percent of the residents have some type of public health insurance like Medicare, Medicaid, Veterans Affairs (VA), or TRICARE. About 73.68 percent of the residents have private health insurance, either through their employer or direct purchase. Military veterans should know that percent of the residents in the ZIP Code of 17959 have VA health insurance. Also, percent of the residents receive TRICARE.

For the 363 residents under the age of 18, there is an estimate of 1 pediatricians in a 20-mile radius of 17959. An estimate of 1 geriatricians or physicians who focus on the elderly who can serve the 280 residents over the age of 65 years.

In a 20-mile radius, there are 875 health care providers accessible to residents in 17959, New Philadelphia, Pennsylvania.

## Prostate Cancer Score Analysis: New Philadelphia, PA (ZIP Code 17959)

This analysis provides an assessment of the healthcare landscape in New Philadelphia, Pennsylvania (ZIP code 17959), specifically focusing on factors relevant to prostate cancer care. The goal is to evaluate the availability and quality of resources, including primary care access, physician-to-patient ratios, and the adoption of modern healthcare practices like telemedicine, all of which contribute to a comprehensive Prostate Cancer Score.

The foundation of effective prostate cancer management lies in accessible and proactive primary care. Early detection through regular screenings and prompt referrals to specialists are critical. The availability of primary care physicians (PCPs) within the local community is therefore a primary indicator. In New Philadelphia, the density of PCPs per capita needs careful examination. A low physician-to-patient ratio can lead to delayed appointments, longer wait times, and potentially, a delay in diagnosis and treatment. Data on the number of PCPs actively practicing within the ZIP code, coupled with population estimates, is essential to calculate this ratio. Publicly available data from the Pennsylvania Department of Health, the U.S. Census Bureau, and potentially local hospital systems will be critical for this calculation.

Beyond sheer numbers, the quality of primary care is paramount. The analysis must consider the accreditation and ratings of local primary care practices. Are they affiliated with reputable hospitals or health systems? Do they participate in quality improvement programs? Patient reviews, accessible through platforms like Healthgrades or Vitals, provide valuable insights into patient satisfaction, communication skills, and the overall patient experience. Positive reviews often reflect a practice's commitment to patient-centered care, which is particularly important for men navigating the complexities of prostate cancer diagnosis and treatment.

The availability of specialists, particularly urologists, is another crucial component of the Prostate Cancer Score. While PCPs are vital for initial screening and referral, urologists are the experts in diagnosing and managing prostate cancer. The analysis needs to identify the number of urologists practicing within a reasonable geographic radius of New Philadelphia, considering factors like travel time and accessibility. This includes assessing the types of services offered by these urologists, such as prostate-specific antigen (PSA) testing, biopsies, and various treatment options like surgery, radiation therapy, and hormone therapy.

The adoption of telemedicine is becoming increasingly important in healthcare. Telemedicine can improve access to care, especially for patients in rural areas or those with mobility issues. The analysis should assess the extent to which local primary care practices and urologists offer telemedicine consultations, remote monitoring, and virtual follow-up appointments. This includes evaluating the technology infrastructure, the availability of telehealth platforms, and the training of healthcare providers in utilizing these tools effectively. The ability to access care remotely can significantly impact the convenience and timeliness of care for men with prostate cancer.

Mental health support is an often-overlooked but critical aspect of prostate cancer care. A cancer diagnosis, and the subsequent treatment, can have a significant impact on a patient's emotional and psychological well-being. The analysis must evaluate the availability of mental health resources within the community, including access to therapists, counselors, and support groups. Are there mental health professionals who specialize in working with cancer patients? Are support groups available specifically for men with prostate cancer and their families? The integration of mental health services into the overall care plan is essential for addressing the emotional challenges associated with the disease.

Standout practices within New Philadelphia should be identified. This requires a deeper dive into the practices' reputations, services, and patient outcomes. Practices that demonstrate a commitment to early detection, patient education, and comprehensive care should be highlighted. This could include practices that actively promote PSA screening, offer patient education materials, or have established relationships with support groups. Practices that are early adopters of telemedicine or other innovative technologies should also be recognized.

The evaluation of these factors will allow for the development of a Prostate Cancer Score for New Philadelphia. This score would represent a composite measure of the community's ability to provide quality prostate cancer care. The score would be based on a weighted average of the various factors discussed above, including physician-to-patient ratios, primary care quality, specialist availability, telemedicine adoption, and mental health resources. The weighting of each factor would reflect its relative importance in the overall assessment of care.

Data collection and analysis will be a continuous process. The healthcare landscape is constantly evolving, and the availability of resources can change over time. Regular updates to the Prostate Cancer Score will be necessary to ensure its accuracy and relevance. This requires ongoing monitoring of physician availability, practice ratings, telemedicine adoption, and the availability of mental health resources.

The final Prostate Cancer Score for New Philadelphia will provide valuable information for residents, healthcare providers, and policymakers. It can be used to identify areas of strength and weakness in the local healthcare system and to guide efforts to improve access to care and patient outcomes. The score can also be used to compare New Philadelphia to other communities and to track progress over time.

The creation of this score requires a thorough and data-driven approach. The analysis must be comprehensive, objective, and transparent. The goal is to provide a clear and concise assessment of the healthcare landscape in New Philadelphia, with a specific focus on prostate cancer care. This will help inform the community and guide future improvements in healthcare delivery.

For a detailed, interactive map visualizing the healthcare resources and prostate cancer care landscape in New Philadelphia, PA (ZIP Code 17959), explore the power of CartoChrome maps.